Abortion


"KFF graphic with white text on a purple background that reads "Interactive Dashboard: Abortion in the United States." The graphic also has photo illustrations of the Supreme Court and abortion medication."

The Abortion in the United States Dashboard is an ongoing research project tracking state abortion policies and litigation following the overturning of Roe v. Wade. It features a continuously-updated map tracking the status of abortion bans across the United States, as well as briefs on topics such as medication abortion, insurance coverage, ballot measures, legal developments, and racial and ethnic disparities. It also offers a jumping off point to the latest national and state-specific abortion policies and statistics. Visit the Dashboard →


Filter

211 - 220 of 290 Results

  • Poll Finds Most Americans Oppose the Trump Administration’s Changes to Restrict Title X Family Planning Funds from Clinics that also Provide or Refer for Abortion

    News Release

    A new KFF poll of the public’s views on reproductive health issues finds most Americans, including majorities of women of reproductive age, are concerned that access to women’s reproductive health and preventive care services may be limited by the Trump administration’s changes to Title X, the nation’s federal family planning program. The poll examines the public’s views of major regulatory changes to the Title X program, which funds nearly 4,000 clinics nationally to pay for…

  • Web Briefing for Journalists – Reproductive Health in the Trump Era: Implications of Recent Federal and Judicial Action

    Event Date:
    Event

    The day after the midterm elections, the Trump Administration moved forward with anticipated regulatory changes governing employer exemption from the Affordable Care Act’s (ACA) contraceptive coverage mandate based on religious or moral objections. That same day, a proposed rule was issued changing how health plans in states that do not ban abortion coverage from their ACA Marketplace plans must separately bill and collect payments for that coverage. The Trump Administration has also proposed changes to…

  • New Analysis Reveals Gaps in Abortion Coverage for Employees with Employer-Sponsored Plans

    News Release

    New analysis of KFF’s 2019 Employer Benefits Survey finds that 10% of workers covered by employer-sponsored health insurance are employed at a firm that has asked their insurer or third party administrator to exclude abortion coverage from their health plan. Employer-sponsored coverage is the primary source of health benefits in the U.S., covering 153 million Americans. Four percent of covered workers are employed at firms that exclude coverage of abortion under any circumstance and 6%…

  • How Pending Health-Related Lawsuits Could be Impacted by the Incoming Trump Administration

    Issue Brief

    This brief provides an overview of current lawsuits in health policy including preventive services, abortion care, gender affirming care, Medicare drug price negotiations, nursing home staffing rules, private coverage consumer protections, and protections and health coverage for Deferred Action for Childhood Arrivals (DACA) recipients; how they may be affected by the incoming Trump administration; and the implications of their potential outcomes.

  • Compare the Candidates on Health Care Policy

    Feature

    The side-by-side comparison tool provides a quick overview of former President Trump's and Vice President Harris' records, positions, public statements, and proposed policies on a range of key health care topics.

  • COVID-19 Puts Medication Abortion in the Spotlight

    News Release

    A new Coronavirus Policy Watch post from KFF explores how state responses to limit abortion access during the COVID-19 pandemic has drawn renewed attention to the provision of medication abortion using telemedicine approaches.  Medication abortion via telemedicine is a method that can be used to safely provide women with access to abortion care while social distancing, preserving personal protective equipment, and limiting risk of exposure to coronavirus. A new telemedicine protocol --“no-test” medication abortions-- has…